CN101658582A - Chinese medicinal powder having effect of dissolving stasis and relieving pain - Google Patents
Chinese medicinal powder having effect of dissolving stasis and relieving pain Download PDFInfo
- Publication number
- CN101658582A CN101658582A CN200810054327A CN200810054327A CN101658582A CN 101658582 A CN101658582 A CN 101658582A CN 200810054327 A CN200810054327 A CN 200810054327A CN 200810054327 A CN200810054327 A CN 200810054327A CN 101658582 A CN101658582 A CN 101658582A
- Authority
- CN
- China
- Prior art keywords
- chinese medicinal
- effect
- medicinal powder
- powder
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of Chinese medicinal preparations, and relates to Chinese medicinal powder having the effect of dissolving stasis and relieving pain, which comprises the following Chinese medicinal components: swordlike atractylodes rhizome, amur corktree bark, sappan wood, Japanese honeysuckle stem and medicinal cyathula root of which the weight ratio is 150-250:150-250:50-150:50-150:50-150. The Chinese medicaments are ground into fine powder and then packaged every 600 to 800 grams. When used, the Chinese medicinal powder is prepared into a paste by 0.05 percent nitrofurazone and 75 percent alcohol of which the ratio is 5:1, and then the pasty Chinese medicinal powder is applied on affected parts through a general application carrier for fixing. The pasty Chinese medicinal powder is applied once every two days, and takes effect after 2 to 5 times. The Chinese medicinal powder has the obvious treatment effect; and compared with the prior simple internal medicamentsfor treatment, the Chinese medicinal powder has short course of treatment and good treatment effect.
Description
Technical field
The invention belongs to field of traditional Chinese.
Background technology
Thromboangiitis obliterans and vein fluid infusion induced phlebitis, the traditional Chinese medical science is called " BI-syndrome involved the blood vessels ".Radix Cyathulae in the side, Lignum Sappan blood circulation promoting and blood stasis dispelling are joined Cortex Phellodendri, Caulis Lonicerae heat clearing away collateral dredging.Each medicine share to have and significantly dissolves thrombosis, expansion peripheral blood vessel, microcirculation improvement, the effect of mediation blood vessels.Humid skin, muscle and joint are red, swollen, Burning Pain, gouty arthritis, originally the former belong to YANG syndrome, pus does not form, and is local red and swollen hard, scorching hot pain person, the latter gathers at blood and tissue for uric acid, take advantage of the occasion at articular surface, joint capsule, ligament and subchondral bone cortex and epiphysis, the joint skin of being injured is red, swollen, hot, shinny and pain.
Summary of the invention
The present invention aims to provide a kind of Chinese powder medicine with effect of dissolving stasis and relieving pain, is used for the treatment of various arthritis.
The present invention is made up of following traditional Chinese medicine components by weight ratio, Rhizoma Atractylodis 150 ~ 250, Cortex Phellodendri 150 ~ 250, Lignum Sappan, Caulis Lonicerae, Radix Cyathulae each 50 ~ 150.
To add medicine to grinds to the powder altogether, per 600 ~ 800 gram packing.Become 5: 1 furnishing pasty states with 75% ethanol with 0.05% nitrofural during use, be applied to the affected part by the general carrier that sticks, fixing.1 time on the per 2nd, 2 ~ 5 times is visible effect.
Cortex Phellodendri contains multiple alkaloid, is mainly berberine, and inferior is that palm leaf is put own alkali, magnoline, phellodendrine, jateorhizine, Dauricine etc.The tool heat clearing and inflammation relieving, blood stasis removing dehumidifying, detoxicating and resolving stagnation of pathogens effect.Rhizoma Atractylodis have along volatilization, mainly in the oil contain atractylone, hinesol, β-by folic alcohol and contain atractydin, Rhizoma Atractylodis alkynol, acetyl Rhizoma Atractylodis alkynol, β-selinene and elemol etc.That tool is let out is wet, remove the wind and cold effect.The Lignum Sappan master contains haematoxylin, Lignum Sappan phenol and volatile oil (Water in oil celery alkene, ocimene), tannic acid etc.Has removing blood stasis to reduce swelling, the effect of promoting the circulation of blood regulating QI to relieve pain.Caulis Lonicerae contains different green former calculation, chlorogenic acid, luteolin and 7-glucoside, inositol, volatile oil, Saponin and tannic acid etc.The tool heat-clearing and toxic substances removing is treated the effect of toxic swelling carbuncle sore.The Caulis et folium stauntoniae master contains ecdysterone, red sterone, cyasterone etc.The effect of tool removing blood stasis with potent drugs dispelling malignant blood.Share with medicine-feeding, have tangible blood stasis dispelling removing dampness and detoxicating, dispersing cold for relieving pain, thrombus, the expansion peripheral blood vessel promotes the absorption of inflammatory exudation, the effect of microcirculation improvement is separated damp and hot, detumescence, pain relieving, thrombolytic thereby reach.The detoxifcation of relieving inflammation or internal heat of Cortex Phellodendri, Caulis Lonicerae, dissipating blood stasis for subsidence of swelling, compatibility Radix Cyathulae, Lignum Sappan are share, and play promoting flow of QI and blood altogether, the detoxifcation of relieving inflammation or internal heat, the merit of reducing swelling and alleviating pain.
Curative effect of the present invention is obvious, than used interior application treatment, short treating period, good effect merely in the past.
The specific embodiment
Example 1: Rhizoma Atractylodis 2000g, Cortex Phellodendri 2000g, Lignum Sappan, Caulis Lonicerae, each 1000g of Radix Cyathulae.
To add medicine to grinds to the powder altogether, per 600 ~ 800 gram packing.Become 5: 1 furnishing pasty states with 75% ethanol with 0.05% nitrofural during use, be applied to the affected part by the general carrier that sticks, fixing.1 time on the per 2nd, 2 ~ 5 times is visible effect.
Example 2: Rhizoma Atractylodis 1500g, Cortex Phellodendri 1500g, Lignum Sappan, Caulis Lonicerae, each 500g of Radix Cyathulae.
To add medicine to grinds to the powder altogether, per 600 ~ 800 gram packing.Become 5: 1 furnishing pasty states with 75% ethanol with 0.05% nitrofural during use, be applied to the affected part by the general carrier that sticks, fixing.1 time on the per 2nd, 2 ~ 5 times is visible effect.
Example 3: Rhizoma Atractylodis 2500g, Cortex Phellodendri 2500g, Lignum Sappan, Caulis Lonicerae, each 1500g of Radix Cyathulae.
To add medicine to grinds to the powder altogether, per 600 ~ 800 gram packing.Become 5: 1 furnishing pasty states with 75% ethanol with 0.05% nitrofural during use, be applied to the affected part by the general carrier that sticks, fixing.1 time on the per 2nd, 2 ~ 5 times is visible effect.
Clinical verification: treat in 40 routine thromboangiitis obliteranss and the vein fluid infusion induced phlebitis male 24 examples, women 16 examples, 41 ~ 71 years old age.
Clinical treatment: adopt powder of the present invention, become 5: 1 furnishing pasty states with 75% ethanol, be applied to the affected part by the general carrier that sticks with 0.05% nitrofural, fixing.1 time on the per 2nd, 10 days is a course of treatment.
Efficacy determination: effectively: clinical cardinal symptom and sign disappear, and resume work; Take a turn for the better: clinical cardinal symptom obviously alleviates, and takes care of oneself; Invalid: clinical symptoms and sign do not have improvement.
The result: effective 34 examples, 5 examples that take a turn for the better, invalid 1 example, effective percentage reaches 97.5%.
Claims (2)
1, have the Chinese powder medicine of effect of dissolving stasis and relieving pain, it is characterized in that, form by following traditional Chinese medicine components by weight ratio, Rhizoma Atractylodis 150 ~ 250, Cortex Phellodendri 150 ~ 250, Lignum Sappan, Caulis Lonicerae, Radix Cyathulae each 50 ~ 150.
2, the Chinese powder medicine with effect of dissolving stasis and relieving pain according to claim 1 is characterized in that, described Chinese medicine ingredients one following weight ratio is formed, Rhizoma Atractylodis 200, Cortex Phellodendri 200, Lignum Sappan, Caulis Lonicerae, Radix Cyathulae each 100.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810054327A CN101658582A (en) | 2008-08-28 | 2008-08-28 | Chinese medicinal powder having effect of dissolving stasis and relieving pain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810054327A CN101658582A (en) | 2008-08-28 | 2008-08-28 | Chinese medicinal powder having effect of dissolving stasis and relieving pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101658582A true CN101658582A (en) | 2010-03-03 |
Family
ID=41786982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810054327A Pending CN101658582A (en) | 2008-08-28 | 2008-08-28 | Chinese medicinal powder having effect of dissolving stasis and relieving pain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101658582A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488790A (en) * | 2011-12-11 | 2012-06-13 | 孙爱莲 | External Chinese traditional medicine transfusion plaster for preventing and treating phlebitis |
| CN103494887A (en) * | 2013-10-08 | 2014-01-08 | 广州加原医药科技有限公司 | Chinese medicine composition for treating knee arthritis and preparation method thereof |
-
2008
- 2008-08-28 CN CN200810054327A patent/CN101658582A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488790A (en) * | 2011-12-11 | 2012-06-13 | 孙爱莲 | External Chinese traditional medicine transfusion plaster for preventing and treating phlebitis |
| CN102488790B (en) * | 2011-12-11 | 2013-12-18 | 孙爱莲 | External Traditional Chinese medicine transfusion plaster for preventing and treating phlebitis |
| CN103494887A (en) * | 2013-10-08 | 2014-01-08 | 广州加原医药科技有限公司 | Chinese medicine composition for treating knee arthritis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101347536B (en) | External-use preparation for treating traumatic injury | |
| CN1853703A (en) | Obtundent healing paste for treating burn and scald | |
| CN101401860A (en) | Externally-applied medicament composition for treating dermatosis | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN101879267B (en) | Compound tincture for treating foot helosis | |
| CN103536850B (en) | A kind of Chinese medicine of internal and external application treatment verruca plana | |
| CN101658582A (en) | Chinese medicinal powder having effect of dissolving stasis and relieving pain | |
| CN100355443C (en) | Medicinal liquor for treating wind-cold, numbness and swelling pain disease | |
| CN103784550A (en) | Traditional Chinese medicinal composition for relieving swelling and pain and preparation thereof | |
| CN102784311B (en) | Traditional Chinese medicine composition for curing women's puerperal diseases and preparation method of traditional Chinese medicine composition | |
| CN102824608B (en) | Externally used Chinese herba preparation for treating peripheral vascular disease | |
| CN102824421B (en) | Method for preparing Chinese medicinal lotion for treating surprised type closed fracture | |
| CN104383062B (en) | External traditional Chinese medicine unguent for treating senile refractory pruritus | |
| CN103211909A (en) | Traditional Chinese medicine composition for treating dandruff | |
| CN102389549B (en) | Traditional Chinese medicinal composition for treating psoriasis | |
| CN105998461A (en) | Pill for treating rarefaction of bones and preparation and taking method thereof | |
| CN106138261A (en) | A kind of external use liquid treating tinea unguium | |
| CN105596785A (en) | Traditional Chinese medicine composition for treating skin keratosis symptom | |
| CN105169054A (en) | Traditional Chinese medicine preparation for treating acute and chronic osteoarthritis and preparation method thereof | |
| CN104940869A (en) | Traditional Chinese medicine composition for treating pain in the neck shoulder low-back and long-term denervation, and preparation method thereof | |
| CN104000975A (en) | Oral medicament for treating glaucomatocy clitic crisis syndrome | |
| CN104721439A (en) | Blood stasis eliminating and blood circulation promoting traditional Chinese medicine | |
| CN103028049A (en) | Traditional Chinese medicine composition for treating tinea manuum and preparation method of composition | |
| CN109248246A (en) | A kind of Chinese medicine composition and preparation method thereof for treating pruitus and chronic eczema | |
| CN105311490A (en) | Traditional Chinese medicine capable of treating rheumatic osteoarthritis caused by sprain injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100303 |